Abstract: A color reflective display panel including a reflective display panel and a color filter array is provided. The color filter array is disposed on the reflective display panel. The color filter array includes a plurality of pixel units. Each pixel unit includes one or more first pixels having a first color, one or more second pixels having a second color, and one or more third pixels having a third color. The ratio of the area of the third pixels to the area of the pixel unit is less than one-third.

Abstract: Use of an exosome derived from decidual natural killer (dNK) cells or a dNK cell subset in the preparation of a drug and an auxiliary therapeutic agent for infertility-related diseases is provided. Experiments have confirmed that the exosome treats the endometrial growth disorder-related diseases by promoting increase of endometrial thickness, increasing endometrial cell viability, reducing endometrial cell damage, promoting VEGF expression, and maintaining stemness and stimulating proliferation of endometrial stromal cells, such that a conception rate for endometrial injury model mice increases from 20% to 50%-70%; and the exosome treats the maternal-fetal immune tolerance disorder-related diseases by exerting immune tolerance, reducing a spontaneous abortion rate, and increasing a helper T cell level.

Abstract: Anti-reflective assemblies comprise: a high dielectric permittivity substrate comprising a ceramic and a nonporous multilayer anti-reflective film contacting or adhesively bonded to the substrate. The nonporous multilayer anti-reflective film comprises sequential first, second, and third layers of sequentially decreasing dielectric permittivity. Each layer comprises a respective polymer matrix and filler particles.

Abstract: An image processing method, including the following steps: receiving an original image signal, wherein the original image signal includes a plurality of original pixel values; identifying an edge of at least one object in the original image signal to generate a contour image signal; and correcting the original image signal according to the contour image signal to generate an enhanced image signal.

Abstract: Disclosed are compounds of Formula (I): or a salt thereof, wherein: X is CR6 or N; Y is CR3 or N; R1, R2, R3, R4, R5, R6, R7, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGK?) and diacylglycerol kinase zeta (DGK?), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

Abstract: A reflective display with a color compensation layer includes a driving substrate, a display medium layer located on the driving substrate, a color filter array, an adhesive layer located on the display medium layer, and a color compensation layer. The driving substrate includes a first sub-pixel region, a second sub-pixel region, and a third sub-pixel region. The color filter array includes a red color resist, a green color resist, and a blue color resist. The color filter array and the color compensation layer are located at opposite two sides of the adhesive layer. The color compensation layer includes a first blue ink layer. A vertical projection of the green color resist on the driving substrate overlaps the second sub-pixel region. A vertical projection of the first blue ink layer on the driving substrate at least partially overlaps the second sub-pixel region.

Abstract: The disclosure provides a mower. The mower includes a vehicle frame, a walking assembly, a working assembly, a seat and a battery pack. The walking assembly includes a first walking wheel assembly and a second walking wheel assembly connected with the vehicle frame. The first walking wheel assembly and/or the second walking wheel assembly includes a main walking wheel and a hub motor, the main walking wheel is connected with the hub motor, and the hub motor is arranged outside a side of the vehicle frame. The working assembly is connected with the vehicle frame. The seat is arranged on the vehicle frame. The battery pack is lowered and mounted on the vehicle frame and extends below the seat.

Abstract: Disclosed are compounds of Formula (I): or a salt thereof, wherein: R1, R2, R3, and R4 are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGK ?) and diacylglycerol kinase zeta (DGK?), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

Abstract: A color filter array includes a first color resist, a second color resist, and a third color resist. The first color resist has a first color, the second color resist has a second color, and the third color resist has a third color. A transparency of the third color resist is greater than transparencies of the first color resist and the second color resist. The first color resist has a first edge and a second edge arranged along a first direction. The second color resist has a first edge and a second edge arranged along a first direction. The first color resist and the second color resist are arranged along a second direction. The first edge of the first color resist, the second edge of the second color resist, and the second edge of the first color resist are arranged sequentially along the first direction.

Abstract: A reflective display device includes an electrophoretic display (EPD) module, an optical layer, a color filter layer, and at least one quantum dot (QD). The optical layer is located above the electrophoretic display module. The color filter layer is located on the optical layer. The quantum dot is located between the optical layer and the electrophoretic display module. When first light passes through the optical layer and transmits to the quantum dot, the quantum dot emits second light, and the electrophoretic display module is configured to reflect the second light to irradiate outwards from the color filter layer.

Abstract: A color electrophoretic display includes a display region, a pixel array, a display medium layer, an optical layer, a first color filter array, and a second color filter array. The display region includes multiple sub-pixel regions. The pixel array corresponds to the display region in position. The display medium layer is located on the pixel array. The optical layer is located on the display medium layer. The first color filter array is located on the optical layer. The second color filter array is located between the display medium layer and the optical layer.

Abstract: Pharmaceutical compositions, and a method of stabilizing pharmaceutical compositions having clevidipine, or any pharmaceutically acceptable salt thereof, as the active ingredient is described. The method includes the slowing down or inhibiting of the oxidation pathway of clevidipine. This can be accomplished by reducing the amount the pharmaceutical composition is exposed to oxygen and/or light during the manufacturing and storing processes. According to this method, oxygen must be removed or replaced, or light must be sufficiently blocked such that light energy cannot reach the active ingredient of the composition, or is reduced to a level that the light-induced oxidation reaction converting clevidipine to H324/78 is minimized, such that the total detectable level of H324/78 in a given composition sample does not exceed about 0.2% on a weight-by-weight basis, or the ratio of clevidipine to H324/78 is equal to or greater than about 450 to 1 on a weight-to-weight basis.

Abstract: Disclosed are compounds of Formula (I): or a salt thereof, wherein: R1, R2, R3, R4, R5, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGK?) and diacylglycerol kinase zeta (DGK?), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

Abstract: A color filter array includes a first color resist having a first color, a second color resist having a second color different from the first color, and a third color resist having a second color different from the first color and the second color. The first color resist includes multiple sections. The second color resist includes multiple sections. The third color resist includes multiple sections. When viewed in a plan view, the sections of the first color resist collectively arranged as a continuous S shape, the sections of the second color resist collectively arranged as a continuous S shape, and the sections of the third color resist collectively arranged as a continuous S shape.

Abstract: Provided are inhibitors of diacylglycerol kinases (DGK) and methods for treating diseases that would benefit from the stimulation of the immune system, such as cancer and infections diseases, comprising administering a DGK inhibitor in combination with an antagonist of the PD 1/PD-L 1 axis and/or an antagonist of CTLA4.

Abstract: Disclosed are compounds of Formula (I) or a salt thereof, wherein: R1, R2, R3, R4, R5, R6, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGK?) and diacylglycerol kinase zeta (DGK?), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

Abstract: A front plate laminate structure includes a display medium layer, a top adhesive layer, a transparent substrate, a transparent conductive film, and a color filter layer. The top adhesive layer is located on the display medium layer. The transparent substrate is located on the top adhesive layer. The transparent conductive film is located between the transparent substrate and the top adhesive layer. The transparent conductive film includes a bottom surface facing the top adhesive layer. The color filter layer is located between the transparent substrate and the display medium layer.

Abstract: Disclosed are compounds of Formula (I): or a salt thereof, wherein: R1, R2, R3, R4, R5, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGK?) and diacylglycerol kinase zeta (DGK?), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

Abstract: An image processing method, including the following steps: receiving an original image signal, wherein the original image signal includes a plurality of original pixel values; identifying an edge of at least one object in the original image signal to generate a contour image signal; and correcting the original image signal according to the contour image signal to generate an enhanced image signal.

Abstract: A soluble dimeric immunoadhesin includes a dimerized first polypeptide chain and a dimerized second polypeptide chain. The first polypeptide chain has a general formula of Z1-Z2, and the second polypeptide chain has a general formula of Y1-Y2. Z1 is (i) an extracellular domain of a first cell surface receptor or a functional variant or fragment thereof, or (ii) a first cytokine or a functional variant or fragment thereof; Z2 is a dimerization domain of an immunoglobulin constant region or a functional variant or fragment thereof. Y1 is an extracellular domain of a second cell surface receptor or a functional variant or fragment thereof, or (ii) a second cytokine or a functional variant or fragment thereof. Y2 is a dimerization domain of an immunoglobulin constant region or a functional variant or fragment thereof. A dimeric protein can be used for the treatment and prevention of infertility-related diseases.